Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online January 19, 2006
Stem Cells Vol. 24 No. 5 May 2006, pp. 1218 -1225
doi:10.1634/stemcells.2005-0020; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0020v1
2005-0020v2
24/5/1218    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koellensperger, E.
Right arrow Articles by Pallua, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koellensperger, E.
Right arrow Articles by Pallua, N.

TISSUE-SPECIFIC STEM CELLS

Human Serum from Platelet-Poor Plasma for the Culture of Primary Human Preadipocytes

Eva Koellensperger, Dennis von Heimburg, Marta Markowicz, Norbert Pallua

Department of Plastic Surgery and Hand Surgery, Burns Center, University Hospital, Aachen University of Technology, Aachen, Germany

Key Words. Preadipocyte • Differentiation • Proliferation • Platelet-derived growth factor • Epidermal growth factor • Basic fibroblast growth factor • Adipose tissue engineering

Correspondence: Eva Koellensperger, M.D., Department of Plastic and Hand Surgery, University of Heidelberg, Ludwig-Guttmannstrasse 13, 67071 Ludwigshafen, Germany. Telephone: +49-621-6810-0; Fax: +49-621-6810-2327; e-mail: e.koellensperger{at}gmx.net

Received January 14, 2005; accepted for publication December 21, 2005.
In adipose tissue engineering, the use of human serum is essential to achieve the goal of an autologous system. Serum from conventional human plasma (SCP) contains platelet-derived growth factor (PDGF), a growth factor known to be both a potent inhibitor of adipose differentiation and also the most important stimulator of proliferation in human serum. Serum from platelet-poor plasma (SPPP) is considered to be PDGF-deprived and should therefore inhibit the differentiation of preadipocytes to adipocytes to a lesser extent. Effective cultivation of preadipocytes with SPPP requires compensating for the missing stimulatory PDGF effect on proliferation. However, the addition of other growth factors to the media needs to provide stimulation of proliferation without significant inhibition of differentiation. Primary human preadipocytes were isolated from adipose tissue samples of 10 healthy human donors and cultured under four different medium conditions (SCP, SPPP, SPPP + 1 nM basic fibroblast growth factor [bFGF], and SPPP + 1 nM epidermal growth factor [EGF]) for five generations. Proliferation activity and differentiation capacity were assessed for each sample, generation, and culture condition by calculating doubling time and measuring glycerol-3-phosphate dehydrogenase (GPDH)-specific activity. The use of SPPP resulted in a marked rise in GPDH activity compared with the cells cultured with SCP. Supplementing SPPP with 1 nM bFGF or EGF increased proliferation activity significantly. SPPP can be considered superior to SCP for the culture of primary human preadipocytes in adipose tissue engineering in terms of proliferation activity and differentiation capacity.




This article has been cited by other articles:


Home page
BloodHome page
S. Fitter, A. L. Dewar, P. Kostakis, L. B. To, T. P. Hughes, M. M. Roberts, K. Lynch, B. Vernon-Roberts, and A. C. W. Zannettino
Long-term imatinib therapy promotes bone formation in CML patients
Blood, March 1, 2008; 111(5): 2538 - 2547.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2006 by AlphaMed Press.